About Medicis Pharmaceutical
Medicis Pharmaceutical is a Healthcare company based in Scottsdale (United States) founded in 1988, and was acquired by Bausch Health in September 2012. Specialty pharmaceuticals for dermatological conditions are developed and marketed. Medicis Pharmaceutical has completed 3 acquisitions, including Ascent Pediatrics, Graceway Pharmaceuticals and Liposonix. Its focus areas include Life Sciences, Dermatology, Drugs and Aesthetics. Its legal entity is MEDICIS PHARMACEUTICAL CORPORATION. Its competitors include Revance Therapeutics, Castle Creek Pharma and Dermavant; 3 of its 3 listed competitors have raised funding.
Company details
Medicis Pharmaceutical operates as a specialty pharmaceutical company in the United States and Canada. The company focuses primarily on development of drugs for the treatment of dermatological, aesthetic and podiatric conditions. The company offers a range of products addressing various conditions or aesthetic improvements, including facial wrinkles, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, skin and skin-structure infections, seborrheic dermatitis and cosmesis (improvement in the texture and appearance of skin). The company offers 18 branded products. Its primary brands are PERLANE (hyaluronic acid), RESTYLANE (hyaluronic acid), SOLODYN (minocycline HCl, USP), TRIAZ (benzoyl peroxide), VANOS (fluocinonide) Cream 0.1, and ZIANA (clindamycin phosphate 1.2 and tretinoin 0.025) Gel. The company also sells various other products that it considers less critical to its business. The companys principal branded dermal restorative products include: RESTYLANE, PERLANE, RESTYLANE FINE LINES and RESTYLANE SUBQ are injectable, transparent, stabilized hyaluronic acid gels, which require no patient sensitivity tests in advance of product administration. As of Sep 2012, the company operates as a subsidiary of Valeant Pharmaceuticals.
- Headquarters Scottsdale, United States
- Stage Acquired
- SectorsHealthcare
- Website medicis.com
- Social LinkedIn
- Acquired by Bausch Health (Sep 2012)
- Legal Name Medicis Pharmaceutical Corporation
- Investors
- Investments & AcquisitionsAscent Pediatrics
& 2 more
- Acquired byBausch Health
(Sep 2012)
Investors in Medicis Pharmaceutical
Medicis Pharmaceutical has secured backing from 1 investor. Prominent investors backing the company include Bausch Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Therapeutics for multiple diseases including dermatology and neurology are developed. | 1960 | bauschhealth.com | Laval, Canada |
Investor details for Medicis Pharmaceutical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Medicis Pharmaceutical
15 people are tracked at Medicis Pharmaceutical (2 in leadership, 13 in team).
| Name | Role | Group |
|---|---|---|
Jonah Shacknai | Founder and CEO of Medicis Pharmaceutical | Leadership |
Aimee Gajate | Executive Director, Human Resources | Leadership |
Ben Cheikh Haythem | Chargé Parc Informatique | Team |
Deborah Rafter | Accounts Payable Coordinator | Team |
Kory Newman | Former Manager, Competitive Intelligence And Analytics | Team |
Louise Newhard | Manager | Team |
Pam Sutton | Sr. Administrative Assistant | Team |
Bsn Kelly Wala Rn, Mep-C | Faculty Trainer And Speaker | Team |
Susanna Su Sphr | Sr. Manager, HR & Administration | Team |
Karen Dirstein | Marketing | Team |
Becky Ingram | Clinical Trial Coordinator | Team |
Janet Payne | Nurse Trainer & Speaker | Team |
Mercy Moywaywa | Nurse | Team |
Amal Ouerghi | Déléguée Médicale | Team |
Edi Curri | Manager | Team |
Complete people profiles for Medicis Pharmaceutical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medicis Pharmaceutical
Medicis Pharmaceutical has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Ascent Pediatrics, Graceway Pharmaceuticals and Liposonix.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharmaceutical products are developed and marketed by Graceway Pharmaceuticals. | gracewaypharma.com | Bristol, United States | 2006 | Nov 2011 | $455M | |
Non-surgical and non-invasive treatment to eliminate unwanted fat around waistline | liposonix.com | Hayward, United States | 1999 | Jun 2008 | $150M | |
Approved drugs are reformulated for common pediatric illnesses. | ascentpediatrics.com | Wilmington, United States | 1989 | Oct 2001 | $60M |
Complete acquisition details for Medicis Pharmaceutical
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Medicis Pharmaceutical
5 dated milestones of Medicis Pharmaceutical across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Medicis Pharmaceutical is founded.
- Acquisition Acquires Ascent Pediatrics.
- Acquisition Acquires Liposonix.
- Acquisition Acquires Graceway Pharmaceuticals.
- Exit Acquired by Bausch Health.
Competitors of Medicis Pharmaceutical
Medicis Pharmaceutical has 3 listed competitors in our database, 3 of them funded. They include Revance Therapeutics, Castle Creek Pharma and Dermavant.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| revance.com | 2002 | Newark, United States | $154.56M | 597 | Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | |
| castlecreekpharma.com | 2015 | Basking Ridge, United States | $663.15M | 72 | Drugs for skin diseases, ENT disorders, and rare diseases such as urea cycle disorders | |
| dermavant.com | 2016 | Phoenix, United States | $160M | Small molecule therapeutics for inflammatory skin diseases are developed. |
Detailed competitors of Medicis Pharmaceutical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Medicis Pharmaceutical
Websites that share an audience with Medicis Pharmaceutical (medicis.com).
Websites whose visitors overlap most with Medicis Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| salix.com | 100% | 15.6K | #1,433,848 | View details | |
liaoyuan.com.cn | liaoyuan.com.cn | 100% | – | ||
| ventanamed.com | 100% | View details | |||
mundipharma.net | mundipharma.net | 100% | – | ||
canderm.com | canderm.com | 100% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Medicis Pharmaceutical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Dermatology
3 companies that operate in the same segment as Medicis Pharmaceutical (Dermatology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Medicis Pharmaceutical
Medicis Pharmaceutical was founded in 1988.
Medicis Pharmaceutical is headquartered in Scottsdale, United States. It is registered at Scottsdale, Arizona, United States.
Medicis Pharmaceutical operates as a specialty pharmaceutical company in the United States and Canada. The company focuses primarily on development of drugs for the treatment of dermatological, aesthetic and podiatric conditions. The company offers a range of products addressing various conditions or aesthetic improvements, including facial wrinkles, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, skin and skin-structure infections, seborrheic dermatitis and cosmesis (improvement in the texture and appearance of skin). The company offers 18 branded products. Its primary brands are PERLANE (hyaluronic acid), RESTYLANE (hyaluronic acid), SOLODYN (minocycline HCl, USP), TRIAZ (benzoyl peroxide), VANOS (fluocinonide) Cream 0.1, and ZIANA (clindamycin phosphate 1.2 and tretinoin 0.025) Gel. The company also sells various other products that it considers less critical to its business. The companys principal branded dermal restorative products include: RESTYLANE, PERLANE, RESTYLANE FINE LINES and RESTYLANE SUBQ are injectable, transparent, stabilized hyaluronic acid gels, which require no patient sensitivity tests in advance of product administration. As of Sep 2012, the company operates as a subsidiary of Valeant Pharmaceuticals.
Medicis Pharmaceutical's top competitors include Revance Therapeutics, Dermavant and Castle Creek Pharma.
Medicis Pharmaceutical has made 3 acquisitions, including Ascent Pediatrics, Graceway Pharmaceuticals, and Liposonix.
Medicis Pharmaceutical has 1 investor. Key investors include Bausch Health.
Medicis Pharmaceutical operates through Medicis Pharmaceutical Corporation.
Yes. Medicis Pharmaceutical was acquired by Bausch Health in September 2012.